Quarterly report [Sections 13 or 15(d)]

Net Income (Loss) per Common Share (Tables)

v3.26.1
Net Income (Loss) per Common Share (Tables)
3 Months Ended
Mar. 31, 2026
Net Income (Loss) per Common Share  
Schedule of Potentially Dilutive Securities are Excluded from the Computation of Net Income (Loss) Per Common Share

​

​

​

​

​

​

​

  ​ ​ ​

​

​

​

​

​

March 31,

​

​

2026

  ​ ​ ​

2025

Warrants to purchase Common Stock

​

8,280,725

​

14,396,201

Options to purchase Common Stock

​

—

​

18,896

Unvested Restricted Stock and deferred Restricted Stock

​

638,659

​

3,093,923

Unvested Restricted Stock units and deferred Restricted Stock units

​

1,506,455

​

2,436,705

Total

​

10,425,839

​

19,945,725

Schedule of Weighted Average Number of Shares

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

($ in thousands, except share and per share amounts)

​

2026

​

​

2025

Net income (loss) attributable to common stockholders

​

$

108,365

​

$

(12,715)

Weighted average common shares outstanding - basic

​

​

31,540,595

​

​

26,450,218

Dilutive effect of potential common shares

​

 

6,872,121

​

​

—

Weighted average common shares outstanding - diluted

​

​

38,412,716

​

​

26,450,218

​

​

​

​

​

​

​

Net income (loss) per common share attributable to common stockholders - basic

​

$

3.44

​

$

(0.48)

Net income (loss) per common share attributable to common stockholders - diluted

​

$

2.82

​

$

(0.48)

​